rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1976-5-25
|
pubmed:abstractText |
The leukocyte adherence inhibition (LAI) assay has been modified and automated in order to facilitate its clinical application. This new assay-the capillary tube LAI test-correlated with delayed cutaneous hypersensitivity using streptokinase-streptodornase antigen in 83% of the cases. When tested with a 3 M KC1 lung carcinoma antigen, lung carcinoma patients' leukocytes were more frequently inhibited (55%) than those of controls (normals 6%, other tumors 20%).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0020-7136
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
338-41
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:1254356-Antibodies, Neoplasm,
pubmed-meshheading:1254356-Antigens, Bacterial,
pubmed-meshheading:1254356-Antigens, Neoplasm,
pubmed-meshheading:1254356-Antigens, Viral,
pubmed-meshheading:1254356-Hypersensitivity, Delayed,
pubmed-meshheading:1254356-Immune Adherence Reaction,
pubmed-meshheading:1254356-Immunity, Cellular,
pubmed-meshheading:1254356-Leukocytes,
pubmed-meshheading:1254356-Lung Neoplasms,
pubmed-meshheading:1254356-Neoplasms,
pubmed-meshheading:1254356-Skin Tests
|
pubmed:year |
1976
|
pubmed:articleTitle |
Capillary tube leukocyte adherence inhibition: an assay for cell-mediated immunity in cancer patients.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|